Global Fibromyalgia Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 921473 | Published Date: Sep 2024 | No. of Page: 122 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cymbalta (Duloxetine)
        1.2.3 Savella (Milnacipran)
        1.2.4 Lyrica (Pregabalin)
        1.2.5 Pancuronium
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Fibromyalgia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Fibromyalgia Therapeutics Market Perspective (2016-2027)
    2.2 Fibromyalgia Therapeutics Growth Trends by Regions
        2.2.1 Fibromyalgia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Fibromyalgia Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Fibromyalgia Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Fibromyalgia Therapeutics Industry Dynamic
        2.3.1 Fibromyalgia Therapeutics Market Trends
        2.3.2 Fibromyalgia Therapeutics Market Drivers
        2.3.3 Fibromyalgia Therapeutics Market Challenges
        2.3.4 Fibromyalgia Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Fibromyalgia Therapeutics Players by Revenue
        3.1.1 Global Top Fibromyalgia Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Fibromyalgia Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Fibromyalgia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Fibromyalgia Therapeutics Revenue
    3.4 Global Fibromyalgia Therapeutics Market Concentration Ratio
        3.4.1 Global Fibromyalgia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Therapeutics Revenue in 2020
    3.5 Fibromyalgia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Fibromyalgia Therapeutics Product Solution and Service
    3.7 Date of Enter into Fibromyalgia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Therapeutics Breakdown Data by Type
    4.1 Global Fibromyalgia Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Fibromyalgia Therapeutics Breakdown Data by Application
    5.1 Global Fibromyalgia Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Fibromyalgia Therapeutics Market Size (2016-2027)
    6.2 North America Fibromyalgia Therapeutics Market Size by Type
        6.2.1 North America Fibromyalgia Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Fibromyalgia Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Fibromyalgia Therapeutics Market Size by Type (2016-2027)
    6.3 North America Fibromyalgia Therapeutics Market Size by Application
        6.3.1 North America Fibromyalgia Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Fibromyalgia Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Fibromyalgia Therapeutics Market Size by Application (2016-2027)
    6.4 North America Fibromyalgia Therapeutics Market Size by Country
        6.4.1 North America Fibromyalgia Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Fibromyalgia Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Fibromyalgia Therapeutics Market Size (2016-2027)
    7.2 Europe Fibromyalgia Therapeutics Market Size by Type
        7.2.1 Europe Fibromyalgia Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Fibromyalgia Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Fibromyalgia Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Fibromyalgia Therapeutics Market Size by Application
        7.3.1 Europe Fibromyalgia Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Fibromyalgia Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Fibromyalgia Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Fibromyalgia Therapeutics Market Size by Country
        7.4.1 Europe Fibromyalgia Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Fibromyalgia Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Fibromyalgia Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Fibromyalgia Therapeutics Market Size (2016-2027)
    9.2 Latin America Fibromyalgia Therapeutics Market Size by Type
        9.2.1 Latin America Fibromyalgia Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Fibromyalgia Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Fibromyalgia Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Fibromyalgia Therapeutics Market Size by Application
        9.3.1 Latin America Fibromyalgia Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Fibromyalgia Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Fibromyalgia Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Fibromyalgia Therapeutics Market Size by Country
        9.4.1 Latin America Fibromyalgia Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Fibromyalgia Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Fibromyalgia Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Fibromyalgia Therapeutics Introduction
        11.1.4 Pfizer Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Fibromyalgia Therapeutics Introduction
        11.2.4 Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.2.5 Eli Lilly Recent Development
    11.3 Actavis
        11.3.1 Actavis Company Details
        11.3.2 Actavis Business Overview
        11.3.3 Actavis Fibromyalgia Therapeutics Introduction
        11.3.4 Actavis Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.3.5 Actavis Recent Development
    11.4 Merck Sharp and Dohme
        11.4.1 Merck Sharp and Dohme Company Details
        11.4.2 Merck Sharp and Dohme Business Overview
        11.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Introduction
        11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.4.5 Merck Sharp and Dohme Recent Development
    11.5 Daiichi Sankyo
        11.5.1 Daiichi Sankyo Company Details
        11.5.2 Daiichi Sankyo Business Overview
        11.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction
        11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.5.5 Daiichi Sankyo Recent Development
    11.6 Innovative Med Concepts
        11.6.1 Innovative Med Concepts Company Details
        11.6.2 Innovative Med Concepts Business Overview
        11.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Introduction
        11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.6.5 Innovative Med Concepts Recent Development
    11.7 Meda
        11.7.1 Meda Company Details
        11.7.2 Meda Business Overview
        11.7.3 Meda Fibromyalgia Therapeutics Introduction
        11.7.4 Meda Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.7.5 Meda Recent Development
    11.8 Meiji Seika
        11.8.1 Meiji Seika Company Details
        11.8.2 Meiji Seika Business Overview
        11.8.3 Meiji Seika Fibromyalgia Therapeutics Introduction
        11.8.4 Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.8.5 Meiji Seika Recent Development
    11.9 Switch Biotech
        11.9.1 Switch Biotech Company Details
        11.9.2 Switch Biotech Business Overview
        11.9.3 Switch Biotech Fibromyalgia Therapeutics Introduction
        11.9.4 Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.9.5 Switch Biotech Recent Development
    11.10 Theravance
        11.10.1 Theravance Company Details
        11.10.2 Theravance Business Overview
        11.10.3 Theravance Fibromyalgia Therapeutics Introduction
        11.10.4 Theravance Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.10.5 Theravance Recent Development
    11.11 Zynerba Pharmaceuticals
        11.11.1 Zynerba Pharmaceuticals Company Details
        11.11.2 Zynerba Pharmaceuticals Business Overview
        11.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Introduction
        11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.11.5 Zynerba Pharmaceuticals Recent Development
    11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
        11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
        11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
        11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Introduction
        11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
    11.13 Daiichi Sankyo
        11.13.1 Daiichi Sankyo Company Details
        11.13.2 Daiichi Sankyo Business Overview
        11.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction
        11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.13.5 Daiichi Sankyo Recent Development
    11.14 Forest Pharmaceuticals, Inc.
        11.14.1 Forest Pharmaceuticals, Inc. Company Details
        11.14.2 Forest Pharmaceuticals, Inc. Business Overview
        11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Introduction
        11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.14.5 Forest Pharmaceuticals, Inc. Recent Development
    11.15 Boehringer Ingelheim GmbH
        11.15.1 Boehringer Ingelheim GmbH Company Details
        11.15.2 Boehringer Ingelheim GmbH Business Overview
        11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Introduction
        11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.15.5 Boehringer Ingelheim GmbH Recent Development
    11.16 Pierre Fabre Mdicament
        11.16.1 Pierre Fabre Mdicament Company Details
        11.16.2 Pierre Fabre Mdicament Business Overview
        11.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Introduction
        11.16.4 Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2016-2021)
        11.16.5 Pierre Fabre Mdicament Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Fibromyalgia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cymbalta (Duloxetine)
    Table 3. Key Players of Savella (Milnacipran)
    Table 4. Key Players of Lyrica (Pregabalin)
    Table 5. Key Players of Pancuronium
    Table 6. Key Players of Others
    Table 7. Global Fibromyalgia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Fibromyalgia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Fibromyalgia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Fibromyalgia Therapeutics Market Share by Regions (2016-2021)
    Table 11. Global Fibromyalgia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Fibromyalgia Therapeutics Market Share by Regions (2022-2027)
    Table 13. Fibromyalgia Therapeutics Market Trends
    Table 14. Fibromyalgia Therapeutics Market Drivers
    Table 15. Fibromyalgia Therapeutics Market Challenges
    Table 16. Fibromyalgia Therapeutics Market Restraints
    Table 17. Global Fibromyalgia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Fibromyalgia Therapeutics Market Share by Players (2016-2021)
    Table 19. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Therapeutics as of 2020)
    Table 20. Ranking of Global Top Fibromyalgia Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Fibromyalgia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Fibromyalgia Therapeutics Product Solution and Service
    Table 24. Date of Enter into Fibromyalgia Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2016-2021)
    Table 28. Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Fibromyalgia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Fibromyalgia Therapeutics Revenue Market Share by Application (2016-2021)
    Table 32. Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Fibromyalgia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Fibromyalgia Therapeutics Product
    Table 67. Pfizer Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 68. Pfizer Recent Development
    Table 69. Eli Lilly Company Details
    Table 70. Eli Lilly Business Overview
    Table 71. Eli Lilly Fibromyalgia Therapeutics Product
    Table 72. Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 73. Eli Lilly Recent Development
    Table 74. Actavis Company Details
    Table 75. Actavis Business Overview
    Table 76. Actavis Fibromyalgia Therapeutics Product
    Table 77. Actavis Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 78. Actavis Recent Development
    Table 79. Merck Sharp and Dohme Company Details
    Table 80. Merck Sharp and Dohme Business Overview
    Table 81. Merck Sharp and Dohme Fibromyalgia Therapeutics Product
    Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 83. Merck Sharp and Dohme Recent Development
    Table 84. Daiichi Sankyo Company Details
    Table 85. Daiichi Sankyo Business Overview
    Table 86. Daiichi Sankyo Fibromyalgia Therapeutics Product
    Table 87. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 88. Daiichi Sankyo Recent Development
    Table 89. Innovative Med Concepts Company Details
    Table 90. Innovative Med Concepts Business Overview
    Table 91. Innovative Med Concepts Fibromyalgia Therapeutics Product
    Table 92. Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 93. Innovative Med Concepts Recent Development
    Table 94. Meda Company Details
    Table 95. Meda Business Overview
    Table 96. Meda Fibromyalgia Therapeutics Product
    Table 97. Meda Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 98. Meda Recent Development
    Table 99. Meiji Seika Company Details
    Table 100. Meiji Seika Business Overview
    Table 101. Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 102. Meiji Seika Recent Development
    Table 103. Switch Biotech Company Details
    Table 104. Switch Biotech Business Overview
    Table 105. Switch Biotech Fibromyalgia Therapeutics Product
    Table 106. Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 107. Switch Biotech Recent Development
    Table 108. Theravance Company Details
    Table 109. Theravance Business Overview
    Table 110. Theravance Fibromyalgia Therapeutics Product
    Table 111. Theravance Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 112. Theravance Recent Development
    Table 113. Zynerba Pharmaceuticals Company Details
    Table 114. Zynerba Pharmaceuticals Business Overview
    Table 115. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Product
    Table 116. Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 117. Zynerba Pharmaceuticals Recent Development
    Table 118. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
    Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
    Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Product
    Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
    Table 123. Daiichi Sankyo Company Details
    Table 124. Daiichi Sankyo Business Overview
    Table 125. Daiichi Sankyo Fibromyalgia Therapeutics Product
    Table 126. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 127. Daiichi Sankyo Recent Development
    Table 128. Forest Pharmaceuticals, Inc. Company Details
    Table 129. Forest Pharmaceuticals, Inc. Business Overview
    Table 130. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Product
    Table 131. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 132. Forest Pharmaceuticals, Inc. Recent Development
    Table 133. Boehringer Ingelheim GmbH Company Details
    Table 134. Boehringer Ingelheim GmbH Business Overview
    Table 135. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Product
    Table 136. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 137. Boehringer Ingelheim GmbH Recent Development
    Table 138. Pierre Fabre Mdicament Company Details
    Table 139. Pierre Fabre Mdicament Business Overview
    Table 140. Pierre Fabre Mdicament Fibromyalgia Therapeutics Product
    Table 141. Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
    Table 142. Pierre Fabre Mdicament Recent Development
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fibromyalgia Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Cymbalta (Duloxetine) Features
    Figure 3. Savella (Milnacipran) Features
    Figure 4. Lyrica (Pregabalin) Features
    Figure 5. Pancuronium Features
    Figure 6. Others Features
    Figure 7. Global Fibromyalgia Therapeutics Market Share by Application: 2020 VS 2027
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Fibromyalgia Therapeutics Report Years Considered
    Figure 12. Global Fibromyalgia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Fibromyalgia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Fibromyalgia Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 15. Global Fibromyalgia Therapeutics Market Share by Regions (2022-2027)
    Figure 16. Global Fibromyalgia Therapeutics Market Share by Players in 2020
    Figure 17. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Therapeutics as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Fibromyalgia Therapeutics Revenue in 2020
    Figure 19. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 20. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 21. North America Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Fibromyalgia Therapeutics Market Share by Type (2016-2027)
    Figure 23. North America Fibromyalgia Therapeutics Market Share by Application (2016-2027)
    Figure 24. North America Fibromyalgia Therapeutics Market Share by Country (2016-2027)
    Figure 25. United States Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Fibromyalgia Therapeutics Market Share by Type (2016-2027)
    Figure 29. Europe Fibromyalgia Therapeutics Market Share by Application (2016-2027)
    Figure 30. Europe Fibromyalgia Therapeutics Market Share by Country (2016-2027)
    Figure 31. Germany Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Fibromyalgia Therapeutics Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Fibromyalgia Therapeutics Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Fibromyalgia Therapeutics Market Share by Region (2016-2027)
    Figure 41. China Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Fibromyalgia Therapeutics Market Share by Type (2016-2027)
    Figure 49. Latin America Fibromyalgia Therapeutics Market Share by Application (2016-2027)
    Figure 50. Latin America Fibromyalgia Therapeutics Market Share by Country (2016-2027)
    Figure 51. Mexico Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Fibromyalgia Therapeutics Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Fibromyalgia Therapeutics Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Fibromyalgia Therapeutics Market Share by Country (2016-2027)
    Figure 57. Turkey Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Pfizer Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 61. Eli Lilly Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 62. Actavis Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 63. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 64. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 65. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 66. Meda Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 67. Meiji Seika Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 68. Switch Biotech Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 69. Theravance Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 70. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 71. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 72. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 73. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 74. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 75. Pierre Fabre Mdicament Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Pierre Fabre Mdicament
Frequently Asked Questions
Fibromyalgia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Fibromyalgia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Fibromyalgia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports